Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain
Status:
Terminated
Trial end date:
2018-01-24
Target enrollment:
Participant gender:
Summary
Safety and pharmacokinetics of an abuse-deterrent, extended-release formulation of oxycodone
hydrochloride with a sequestered naltrexone core in children 7-17 with moderate-severe pain.